- US Capitol Capsule: Rare disease research hopeful, but therapy success remains low
- FDA/EMA partner in new 'mutual reliance' initiative
- US Capitol Capsule: Fighting the uphill battle: Stakes high for drug makers
- US Capitol Capsule: Rigid regulations harmful to US entrepreneurship, report charges
- Interview: building on Spiriva – Boehringer Ingelheim's Allan Hillgrove
- INTERVIEW: Dr Reddy's CEO on the 'windshield and rear view mirror'